Germany's financial markets watchdog is looking at whether Bayer fairly disclosed plans for shareholder approval of a capital ...

Federal datasets began disappearing from public view on Jan 31, in response to executive orders from President Donald Trump.

DelveInsight's "ROZLYTREK Market Size, Forecast, and Market Insight Report" highlights the details around ROZLYTREK, an inhibitor of the ...

Leerink Partners 2025 Global Healthcare Conference Call March 12, 2025 11:20 AM ETCompany ParticipantsRoland Chen ...

We recently published a list of the 11 Best Pharma Stocks to Buy According to Hedge Funds. In this article, we are going to ...

The global mast cell tumor treatment market is on a strong growth trajectory, with market projections estimating a valuation of USD 7,836.4 million by 2034. This reflects a steady CAGR of 3.4% from ...

The global autologous cell therapy market, valued at USD 10.12 billion in 2024, is poised for remarkable expansion, reaching a projected valuation of USD 44.55 billion by 2033. This growth, driven by ...

The state Transportation Department will establish a grant program to improve sidewalks around public schools under Senate Bill 141. $38B Highway Backlog: Bill highlights Republican’s highway funding ...

BACKGROUND: Despite the high morbidity and mortality of heart failure with preserved ejection fraction (HFpEF), treatment ...

Market was valued at USD 472.77 Million in 2024 and is expected to reach USD 728.10 Million by 2030, growing at a CAGR of 7.42% during the forecast period. The market is being driven by the increasing ...

As biomarker testing and the demand for tumor-agnostic therapies rise, ROZLYTREK can potentially target a specialized yet valuable market segment. While competition from other TRK inhibitors ...